Lower urinary tract symptoms

From HandWiki - Reading time: 7 min


Short description: Group of clinical symptoms
Lower urinary tract symptoms
Other namesLUTS, prostatism
Diagram of the human urinary system
The lower urinary tract comprises the bladder, urethra, and in men, the prostate.
SpecialtyUrology

Lower urinary tract symptoms (LUTS) are a group of clinical symptoms involving the bladder, urinary sphincter, urethra and, in men, the prostate. The term is more commonly applied to men[1] – over 40% of older men are affected[2][3][4][5] – but lower urinary tract symptoms also affect women.[6] The condition is also termed prostatism in men, but LUTS is preferred.[7]

Symptoms and signs

Symptoms can be categorised into:

Filling (storage) or irritative symptoms

  • Increased frequency of urination
  • Increased urgency of urination
  • Urge incontinence
  • Excessive passage of urine at night

Voiding or obstructive symptoms

  • Poor stream[8] (unimproved by straining)
  • Hesitancy[8] (worsened if bladder is very full)[9]
  • Terminal dribbling[8]
  • Incomplete voiding[8]
  • Urinary retention[10]
  • Overflow incontinence (occurs in chronic retention)[10]
  • Episodes of near retention[10]

As the symptoms are common and non-specific, LUTS is not necessarily a reason to suspect prostate cancer.[7] Large studies of patients have also failed to show any correlation between lower urinary tract symptoms and a specific diagnosis.[11] Also, recently a report of lower urinary tract symptoms even with malignant features in the prostate failed to be associated with prostate cancer after further laboratory investigation of the biopsy.[10]

Causes

Diagnosis

The International Prostate Symptom Score (IPSS) can be used to gauge the symptoms, along with physician examination. Other primary and secondary tests are often carried out, such as a prostate-specific antigen (PSA) test,[17] urinalysis, ultrasound, urinary flow studies, imaging, temporary prostatic stent placement, prostate biopsy and cystoscopy.

Treatment

Treatment will depend on the cause, if one is found. For example; with a UTI, a course of antibiotics would be given[18]; appropriate medication would be administered to treat benign prostatic hyperplasia.

Lifestyle changes

Other treatments include lifestyle advice; for example, avoiding dehydration in recurrent cystitis.[19][20]

Men with prostatic hypertrophy are advised to sit down whilst urinating.[21] A 2014 meta-analysis found that, for elderly males with LUTS, sitting to urinate meant there was a decrease in post-void residual volume (PVR, ml), increased maximum urinary flow (Qmax, ml/s), which is comparable with pharmacological intervention, and decreased the voiding time (VT, s).[22] The improved urodynamic profile is related to a lower risk of urologic complications, such as cystitis and bladder stones.[22]

Physical activity

Physical activity has been recommended as a treatment for urinary tract symptoms. A 2019 Cochrane review of six studies involving 652 men assessing the effects of physical activity alone, physical activity as a part of a self-management program, among others.[23] The evidence from this review states that there are important uncertainties whether physical activity is helpful in men experiencing urinary symptoms caused by benign prostatic hyperplasia.[23]

Medications

With benign prostatic enlargement causes of LUTS, people may be offered a variety of medications (as a single drug or combining them) when there are persistent moderate symptoms:[24]

Surgical treatment

Surgical treatment of LUTS can include:

  • Ablation procedures – used in treating both bladder tumours[25] and bladder outlet obstruction, such as prostate conditions.[26]
  • Bladder-neck incision (BNI)
  • Removal of the prostate – open, robotic, and endoscopic techniques are used.
  • Stenting of the prostate[27] and urethra.
  • Transurethral resection of the prostate (TURP)
  • Transurethral microwave thermotherapy
  • Urethral dilatation, a common treatment for strictures.

Epidemiology

  • Prevalence increases with age. The prevalence of nocturia in older men is about 78%. Older men have a higher incidence of LUTS than older women.[28]
  • Around one third of men will develop urinary tract (outflow) symptoms, of which the principal underlying cause is benign prostatic hyperplasia.[29]
  • Once symptoms arise, their progress is variable and unpredictable with about one third of patients improving, one third remaining stable and one third deteriorating.[30]

See also

References

  1. ↑ "Lower Urinary Tract Symptoms in Women | Doctor". https://patient.info/doctor/lower-urinary-tract-symptoms-in-women-pro. 
  2. ↑ "Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients' atherosclerosis risk level" (in en). Annals of Medicine and Surgery 80. 2022-08-01. doi:10.1016/j.amsu.2022.104137. ISSN 2049-0801. PMID 35846856. 
  3. ↑ "Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years". Urology 72 (2): 318–321. August 2008. doi:10.1016/j.urology.2008.03.057. PMID 18554695. 
  4. ↑ "Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction". BJU International 108 (7): 1132–1138. October 2011. doi:10.1111/j.1464-410X.2010.09993.x. PMID 21231991. 
  5. ↑ "Chapter 38: Etiology, pathophusiology, epidemiology, and natural history of benign prostatic hyperplasia.". Campell's Urology. WB Saunders Co. 2002. p. 1309. 
  6. ↑ "Clinical Guideline for Female Lower Urinary Tract Symptoms". Lower Urinary Tract Symptoms 8 (1): 5–29. January 2016. doi:10.1111/luts.12111. PMID 26789539. 
  7. ↑ 7.0 7.1 "New words for old: lower urinary tract symptoms for "prostatism"". BMJ 308 (6934): 929–930. April 1994. doi:10.1136/bmj.308.6934.929. PMID 8173393. 
  8. ↑ 8.0 8.1 8.2 8.3 "A healthy bladder: a consensus statement". International Journal of Clinical Practice 65 (10): 1026–1036. October 2011. doi:10.1111/j.1742-1241.2011.02763.x. PMID 21923844. 
  9. ↑ Bailey & Love's Short Practice of Surgery (28th ed.). CRC Press. 2023. pp. 1523. ISBN 978-0-367-54811-7. 
  10. ↑ 10.0 10.1 10.2 10.3 "Pathophysiology of lower urinary tract symptoms in the aging male population". Reviews in Urology 7 Suppl 7 (7): S3–S11. 2005. PMID 16986059. 
  11. ↑ Clinical Knowledge Summary; Urological cancer – suspected
  12. ↑ "The prevalence and natural history of urinary symptoms among recreational ketamine users". BJU International 110 (11): 1762–1766. December 2012. doi:10.1111/j.1464-410X.2012.11028.x. PMID 22416998. 
  13. ↑ "Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer". European Urology 64 (6): 865–872. December 2013. doi:10.1016/j.eururo.2012.11.056. PMID 23266239. 
  14. ↑ "IgG4-associated prostatitis complicating autoimmune pancreatitis". Internal Medicine 45 (15): 897–901. 1 Sep 2006. doi:10.2169/internalmedicine.45.1752. PMID 16946571. 
  15. ↑ "IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis". Internal Medicine 46 (24): 1983–1989. 17 Dec 2007. doi:10.2169/internalmedicine.46.0452. PMID 18084121. 
  16. ↑ "Lower urinary tract symptoms that predict microscopic pyuria". International Urogynecology Journal 29 (7): 1019–1028. July 2018. doi:10.1007/s00192-017-3472-7. PMID 28971220. 
  17. ↑ "Prostate-Specific Antigen (PSA) Test – NCI". March 21, 2022. https://www.cancer.gov/types/prostate/psa-fact-sheet. 
  18. ↑ Bono, Michael J.; Leslie, Stephen W. (2026), "Uncomplicated Urinary Tract Infections", StatPearls (Treasure Island (FL): StatPearls Publishing), PMID 29261874, http://www.ncbi.nlm.nih.gov/books/NBK470195/, retrieved 2026-07-10 
  19. ↑ "Lifestyle and Behavioral Therapies for Urinary Incontinence | GLOWM" (in en). http://www.glowm.com/section-view/heading/lifestyle-and-behavioral-therapies-for-urinary-incontinence/item/855. 
  20. ↑ "Urinary Tract Infection (UTI) and Cystitis in Females Treatment & Management: Approach Considerations, Uncomplicated Cystitis in Nonpregnant Patients, Complicated Cystitis in Nonpregnant Women". MedScape. 2026-07-07. https://emedicine.medscape.com/article/233101-treatment. 
  21. ↑ "Influence of voiding posture on urodynamic parameters in men: a literature review". Nederlands Tijdschrift voor urologie. http://www.mednet.nl/wosmedia/1718/mictiehouding_tvu.pdf. 
  22. ↑ 22.0 22.1 "Urinating standing versus sitting: position is of influence in men with prostate enlargement. A systematic review and meta-analysis". PLOS ONE 9 (7). 2014. doi:10.1371/journal.pone.0101320. PMID 25051345. Bibcode: 2014PLoSO...9j1320D. 
  23. ↑ 23.0 23.1 "Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction". The Cochrane Database of Systematic Reviews 4. April 2019. doi:10.1002/14651858.CD012044.pub2. PMID 30953341. 
  24. ↑ Sumedia-Online Professionals. "EAU Guidelines: Management of Non-neurogenic Male LUTS" (in en-US). https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/#5. 
  25. ↑ "Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014". World Journal of Urology 33 (4): 571–579. April 2015. doi:10.1007/s00345-014-1337-y. PMID 24935098. 
  26. ↑ "Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes". Urology 81 (3): 634–639. March 2013. doi:10.1016/j.urology.2012.11.042. PMID 23332997. 
  27. ↑ Fitzpatrick, J. M. (1992). Non-surgical treatment of BPH. Edinburgh: Churchill Livingstone. ISBN 0-443-04642-5. 
  28. ↑ "The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study". BJU International 92 (4): 409–414. September 2003. doi:10.1046/j.1464-410x.2003.04369.x. PMID 12930430. 
  29. ↑ Enlarged prostate gland – treatment, symptoms and cause
  30. ↑ "Risk Factors for Progression or Improvement of Lower Urinary Tract Symptoms in a Prospective Cohort of Men | Journal of Urology" (in en). The Journal of Urology. doi:10.1016/j.juro.2013.06.018. https://www.auajournals.org/doi/10.1016/j.juro.2013.06.018. 

Further reading

  • "Guideline for the primary care management of male lower urinary tract symptoms". BJU International 93 (7): 985–990. May 2004. doi:10.1111/j.1464-410X.2004.04765.x. PMID 15142148. 
  • "American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited". Current Opinion in Urology 22 (1): 34–39. January 2012. doi:10.1097/MOU.0b013e32834d8e87. PMID 22123290. 
  • NHS; Cancer Screening Programmes. Prostate Cancer Risk Management.
Classification




Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Medicine:Lower_urinary_tract_symptoms
25 views |
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF